About us

Our vision and values

Two green trees far away on a green meadow and blue skyAntibiotic resistance is a complex and ever-changing phenomenon deeply influenced by microbial ecology, human behavior and globalization. ReAct was one of the first international networks to articulate the complex nature of antibiotic resistance and its drivers, calling for a holistic view of the problem and solutions that engage all of society.


Our vision: A world free from fear of untreatable infections.

We believe that change towards this vision will depend on engaging with social movements, civil society, community- and consumer organizations, academia, policy makers and those individuals, networks or institutions that generate and analyze health-related knowledge.

We are committed to address the issue of gender inequality. We acknowledge the significance of sex and gender and see this as a necessary challenge which needs to be undertaken in our work on antibiotic resistance, with sensitivity to local contexts and national development plans.


To enable collective action that ensures sustainable and equitable access to effective antibiotics for all.


ReAct works across disciplines to identify and promote best practices, innovative and ecologically grounded solutions to contain antibiotic resistance that contribute to universal health coverage, poverty reduction and global development.

  • We believe that sustainable access to effective antibiotics is part of everyone’s right to health.
  • We view antibiotic effectiveness as an essential public good and as a non-renewable resource.
  • We encourage context-specific solutions to account for the diversity of systems of health care, cultural practices, resource availability, geography and other factors.
  • We promote an ecosystem approach to antibiotic resistance to replace the dominant war metaphor of bacteria as our ‘enemy’, with an understanding of the essential role of microbes and microbial ecology in the health of humans, animals and the planet.
  • We are independent of the pharmaceutical industry and do not accept any financial support from it.